Japan’s Hitachi Soon To Market Precise Protein Spectrometer
This article was originally published in PharmAsia News
Executive Summary
Hitachi High-Technologies of Japan plans to begin marketing soon a highly precise mass spectrometer for analyzing proteins. The trick in analyzing protein is to do so without destroying various molecules that may be attached to the protein. Such molecules are what identify the state of the disease involved and precision in developing more-precise drugs to deal with the disease. Hitachi says its spectrometer is five times as precise as current models and can analyze several thousand proteins in no more than 2.5 hours versus the current 10 hours for current analyzers. (Click here for more - a subscription may be required
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.